KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes

• Active KRAS suppresses Ago2 interaction with endosomes and secretion into exosomes
• KRAS-MEK-ERK signaling promotes Ago2 phosphorylation on serine 387
• S387 phosphorylation inhibits Ago2-endosome association and sorting to exosomes
• Ago2 levels and phosphorylation control secretion of candidate miRNAs in exosomes

SummarySecretion of RNAs in extracellular vesicles is a newly recognized form of intercellular communication. A potential regulatory protein for microRNA (miRNA) secretion is the critical RNA-induced silencing complex (RISC) component Argonaute 2 (Ago2). Here, we use isogenic colon cancer cell lines to show that overactivity of KRAS due to mutation inhibits localization of Ago2 to multivesicular endosomes (MVEs) and decreases Ago2 secretion in exosomes. Mechanistically, inhibition of mitogen-activated protein kinase kinases (MEKs) I and II, but not Akt, reverses the effect of the activating KRAS mutation and leads to increased Ago2-MVE association and increased exosomal secretion of Ago2. Analysis of cells expressing mutant Ago2 constructs revealed that phosphorylation of Ago2 on serine 387 prevents Ago2-MVE interactions and reduces Ago2 secretion into exosomes. Furthermore, regulation of Ago2 exosomal sorting controls the levels of three candidate miRNAs in exosomes. These data identify a key regulatory signaling event that controls Ago2 secretion in exosomes.

Graphical AbstractFigure optionsDownload as PowerPoint slide